Transcutaneous Electrical Acupoint Stimulation(TEAS) for Hepatic and Renal Dysfunction After Pneumoperitoneum

2014-09-22 14:39:17 | BioPortfolio

Published on BioPortfolio: 2014-09-22T14:39:17-0400

Clinical Trials [1075 Associated Clinical Trials listed on BioPortfolio]

Perioperative TEAS to Improve Post Cardiac Surgery Immunosuppression: A Randomized Controlled Clinical Trial

Cardiac surgery usually leads to postoperative immunosuppression, which is characterized by predisposition to develop secondary nosocomial infections and high risk of tumorigenesis and dev...

Different Schemes of Transcutaneous Electric Acupoint Stimulation(TEAS) on Acupuncture Anesthesia

To determine whether treating by transcutaneous electrical acupoint stimulation (TEAS) combined with general anesthetic during peri-operative could alleviate the dosage of anesthetic drugs...

Transcutaneous Electrical Acupoint Stimulation Administered in Peri-operation

This study investigates transcutaneous electrical acupoint stimulation (TEAS) administered in peri-operation for preventing postoperative complications, meanwhile evaluates it's safety and...

Efficiency of Acupuncture-assisted Anesthesia With Single Acupoint or Dual Acupoints in Patients Undergoing Radical Operation of Breast Cancer

The purpose of this study is to compare the effects of dual acupoints and single acupoint TEAS pretreatment on incidence of Post-Mastectomy Pain Syndrome(PMPS) in patients undergoing opera...

Transcutaneous Electrical Acupoint Stimulation (TEAS) on Aged Patients Undergoing Lower Extremity Arthroplasty

This is a single center, randomized, double-blinded, controlled clinical trial. The purpose of this study is to to determine whether treating by transcutaneous electrical acupoint stimulat...

PubMed Articles [21663 Associated PubMed Articles listed on BioPortfolio]

Metal concentrations in traditional and herbal teas and their potential risks to human health.

Food and beverage consumption is an important route for human exposure to metals. Traditional tea (Camellia sinensis) is a widely-consumed beverage, which may contain toxic metals. This study determin...

Risk assessment of pyrrolizidine alkaloids in food of plant and animal origin.

Acute liver toxicity, specifically in the form of hepatic veno-occlusive disease (HVOD), is known from reports on human poisonings following ingestions of 1,2-unsaturated pyrrolizidine alkaloids (PAs)...

Clinical and psychopathological features associated with treatment-emergent mania in bipolar-II depressed outpatients exposed to antidepressants.

Treatment-emergent affective switch (TEAS), including treatment-emergent mania (TEM), carry significant burden in the clinical management of bipolar depression, whereas the use of antidepressants rais...

A Review on the Weight-Loss Effects of Oxidized Tea Polyphenols.

The mechanistic systems in the body through which tea causes weight loss are complex and multi-dimensional. Additionally, the bioactive components in tea such as catechins, caffeine, and products of t...

Bioavailability of phenolic compounds and redox state of murine liver and kidney as sex-dependent responses to phytoextracts.

Plant extracts can be obtained to carry bioactive compounds, useful for prevention and treatment of different illnesses. This also supports the intake of teas as functional beverages. Nonetheless, it ...

Medical and Biotech [MESH] Definitions

Beverages prepared from an infusion of plant tissues.

Beverages used in TRADITIONAL MEDICINE that are prepared from the infusion of plant tissue (HERBAL TEA), and/or animal tissue or other organisms such as FUNGI.

A form of rapid-onset LIVER FAILURE, also known as fulminant hepatic failure, caused by severe liver injury or massive loss of HEPATOCYTES. It is characterized by sudden development of liver dysfunction and JAUNDICE. Acute liver failure may progress to exhibit cerebral dysfunction even HEPATIC COMA depending on the etiology that includes hepatic ISCHEMIA, drug toxicity, malignant infiltration, and viral hepatitis such as post-transfusion HEPATITIS B and HEPATITIS C.

A rare autosomal recessive disease characterized by the deposition of copper in the BRAIN; LIVER; CORNEA; and other organs. It is caused by defects in the ATP7B gene encoding copper-transporting ATPase 2 (EC, also known as the Wilson disease protein. The overload of copper inevitably leads to progressive liver and neurological dysfunction such as LIVER CIRRHOSIS; TREMOR; ATAXIA and intellectual deterioration. Hepatic dysfunction may precede neurologic dysfunction by several years.

Brief reversible episodes of focal, nonconvulsive ischemic dysfunction of the brain having a duration of less than 24 hours, and usually less than one hour, caused by transient thrombotic or embolic blood vessel occlusion or stenosis. Events may be classified by arterial distribution, temporal pattern, or etiology (e.g., embolic vs. thrombotic). (From Adams et al., Principles of Neurology, 6th ed, pp814-6)

More From BioPortfolio on "Transcutaneous Electrical Acupoint Stimulation(TEAS) for Hepatic and Renal Dysfunction After Pneumoperitoneum"

Quick Search


Searches Linking to this Trial